Daniel SontupeMarket Access
Bud BilanichSuccess Coach
Frank BurrellScientific Storytelling
Brenda SnowAuthentic Patient Voice
Matt TurnerPatient Affordability
Stacey GandlerBrand Nourishment
Liz KaneImpactful Strategy
Joey CohenMedication Adherence
Matthew DurhamOmnidynamic Marketing
David LinetskyPoint-of-Care Marketing
Amy GilesIncreasing Engagement
Paul TheisenPatient Acquisition
Pat PurcellMeeting Engagement
Suma Ramadas, PhDMedical Affairs
Phase 1/2 clinical trial combines Regeneron’s PD-1 inhibitor cemiplimab and Inovio’s immunotherapy INO-5401 in ...
UTRECHT, Netherlands, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage ...
CAMBRIDGE, Mass., and BEIJING, China, Nov. 15, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email